US Stock MarketDetailed Quotes

MEIP MEI Pharma

Watchlist
  • 2.3000
  • -0.0900-3.77%
Close Mar 19 16:00 ET
  • 2.3000
  • 0.00000.00%
Post 20:01 ET
15.32MMarket Cap-0.40P/E (TTM)

MEI Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
Total revenue
0
0
33.76%65.3M
0
0
0
647.96%65.3M
19.95%48.82M
-87.23%1.46M
-39.20%5.89M
Operating revenue
--0
--0
33.76%65.3M
--0
--0
--0
647.96%65.3M
19.95%48.82M
-87.23%1.46M
-39.20%5.89M
Cost of revenue
Gross profit
Operating expense
-71.07%3.45M
-16.61%8.35M
-53.43%39.86M
-35.54%8.08M
-55.89%9.83M
-49.89%11.93M
-62.83%10.02M
-26.34%85.58M
-54.59%12.54M
-28.69%22.29M
Selling and administrative expenses
-60.80%3.14M
-20.55%5.19M
-29.69%23.3M
-58.49%4.14M
-35.82%4.61M
-5.63%8.02M
-12.76%6.53M
8.48%33.13M
72.71%9.97M
-19.62%7.18M
-General and administrative expense
-60.80%3.14M
-20.55%5.19M
-29.69%23.3M
-58.49%4.14M
-35.82%4.61M
-5.63%8.02M
-12.76%6.53M
8.48%33.13M
72.71%9.97M
-19.62%7.18M
Research and development costs
-92.13%308K
-9.24%3.16M
-68.43%16.56M
53.46%3.94M
-65.44%5.22M
-74.45%3.91M
-82.09%3.49M
-38.76%52.45M
-88.23%2.57M
-32.32%15.1M
Operating profit
71.07%-3.45M
-115.11%-8.35M
169.20%25.44M
27.07%-8.08M
40.03%-9.83M
-233.65%-11.93M
403.42%55.28M
51.30%-36.76M
31.59%-11.08M
23.97%-16.39M
Net non-operating interest income expense
-67.89%279K
-67.55%355K
-2.03%3.28M
-42.80%608K
-26.23%706K
2.84%869K
127.92%1.09M
1,077.82%3.35M
416.02%1.06M
1,495.00%957K
Non-operating interest income
-67.89%279K
-67.55%355K
-2.03%3.28M
-42.80%608K
-26.23%706K
2.84%869K
127.92%1.09M
1,077.82%3.35M
416.02%1.06M
1,495.00%957K
Other net income (expense)
24,850.00%495K
-900.00%-10K
-791.97%-10.94M
-91,008.33%-10.93M
0.00%-4K
-100.41%-2K
-100.09%-1K
-92.38%1.58M
83.56%-12K
-100.03%-4K
Gain on sale of security
----
----
----
----
----
----
----
-92.28%1.6M
--0
----
Special income (charges)
--500K
----
---10.9M
----
----
--0
----
--0
----
----
-Less:Impairment of capital assets
----
----
--10.9M
----
----
----
----
--0
----
----
-Gain on sale of property,plant,equipment
--500K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-150.00%-5K
-900.00%-10K
-86.36%-41K
-183.33%-34K
0.00%-4K
50.00%-2K
50.00%-1K
-266.67%-22K
---12K
---4K
Income before tax
75.80%-2.68M
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
Income tax
Net income
75.80%-2.68M
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
Net income continuous Operations
75.80%-2.68M
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
Minority interest income
Net income attributable to the parent company
75.80%-2.68M
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
75.80%-2.68M
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
Basic earnings per share
75.90%-0.4
-114.18%-1.2
155.86%2.67
-82.78%-2.76
40.95%-1.37
-207.79%-1.66
439.76%8.46
45.37%-4.78
38.11%-1.51
-77.10%-2.32
Diluted earnings per share
75.90%-0.4
-114.18%-1.2
155.86%2.67
-82.78%-2.76
40.95%-1.37
-207.79%-1.66
439.76%8.46
52.15%-4.78
38.11%-1.51
-77.10%-2.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023
Total revenue 0033.76%65.3M000647.96%65.3M19.95%48.82M-87.23%1.46M-39.20%5.89M
Operating revenue --0--033.76%65.3M--0--0--0647.96%65.3M19.95%48.82M-87.23%1.46M-39.20%5.89M
Cost of revenue
Gross profit
Operating expense -71.07%3.45M-16.61%8.35M-53.43%39.86M-35.54%8.08M-55.89%9.83M-49.89%11.93M-62.83%10.02M-26.34%85.58M-54.59%12.54M-28.69%22.29M
Selling and administrative expenses -60.80%3.14M-20.55%5.19M-29.69%23.3M-58.49%4.14M-35.82%4.61M-5.63%8.02M-12.76%6.53M8.48%33.13M72.71%9.97M-19.62%7.18M
-General and administrative expense -60.80%3.14M-20.55%5.19M-29.69%23.3M-58.49%4.14M-35.82%4.61M-5.63%8.02M-12.76%6.53M8.48%33.13M72.71%9.97M-19.62%7.18M
Research and development costs -92.13%308K-9.24%3.16M-68.43%16.56M53.46%3.94M-65.44%5.22M-74.45%3.91M-82.09%3.49M-38.76%52.45M-88.23%2.57M-32.32%15.1M
Operating profit 71.07%-3.45M-115.11%-8.35M169.20%25.44M27.07%-8.08M40.03%-9.83M-233.65%-11.93M403.42%55.28M51.30%-36.76M31.59%-11.08M23.97%-16.39M
Net non-operating interest income expense -67.89%279K-67.55%355K-2.03%3.28M-42.80%608K-26.23%706K2.84%869K127.92%1.09M1,077.82%3.35M416.02%1.06M1,495.00%957K
Non-operating interest income -67.89%279K-67.55%355K-2.03%3.28M-42.80%608K-26.23%706K2.84%869K127.92%1.09M1,077.82%3.35M416.02%1.06M1,495.00%957K
Other net income (expense) 24,850.00%495K-900.00%-10K-791.97%-10.94M-91,008.33%-10.93M0.00%-4K-100.41%-2K-100.09%-1K-92.38%1.58M83.56%-12K-100.03%-4K
Gain on sale of security -----------------------------92.28%1.6M--0----
Special income (charges) --500K-------10.9M----------0------0--------
-Less:Impairment of capital assets ----------10.9M------------------0--------
-Gain on sale of property,plant,equipment --500K------------------0----------------
Other non- operating income (expenses) -150.00%-5K-900.00%-10K-86.36%-41K-183.33%-34K0.00%-4K50.00%-2K50.00%-1K-266.67%-22K---12K---4K
Income before tax 75.80%-2.68M-114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M
Income tax
Net income 75.80%-2.68M-114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M
Net income continuous Operations 75.80%-2.68M-114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M
Minority interest income
Net income attributable to the parent company 75.80%-2.68M-114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 75.80%-2.68M-114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M
Basic earnings per share 75.90%-0.4-114.18%-1.2155.86%2.67-82.78%-2.7640.95%-1.37-207.79%-1.66439.76%8.4645.37%-4.7838.11%-1.51-77.10%-2.32
Diluted earnings per share 75.90%-0.4-114.18%-1.2155.86%2.67-82.78%-2.7640.95%-1.37-207.79%-1.66439.76%8.4652.15%-4.7838.11%-1.51-77.10%-2.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+7.43%
Coinbase
COIN
+4.75%
Tesla
TSLA
+4.68%
MARA Holdings
MARA
+3.81%
Taylor Morrison Home
TMHC
+2.62%

Unlock the Full List